The Food and Drug Administration approves the first drug to treat children who suffer from a condition what stunts growth.
Dr. Philippe Backeljauw of Cincinnati Children's Hospital says that the drug called Increlex will treat children whose growth failure is related to unusually low levels of a hormone called IGF-1
